
Migraine Science
Comparison of Trigeminal Autonomic Cephalalgias: Cluster Headache vs Paroxysmal Hemicrania vs SUNCT and SUNA vs Hemicrania Continua
Posted on August 04 2023,
| Clinical Features | Cluster Headache | Paroxysmal Hemicrania | SUNCT* & SUNA** | Hemicrania Continua |
|---|---|---|---|---|
| Sex Predominance | Mostly male | Equal male & female | Mostly female | Mostly female |
| Pain Type | Stabbing | Stabbing or pulsating | Stabbing or burning | Varied pain types |
| Pain Severity | Very severe | Very severe | Severe to very severe | Mild to severe |
| Location | Eye or temple | Eye or temple | Eye or temple | Eye, forehead, and/or temple |
| Attack Frequency | 1 every other day to 8 daily | 5 to 40 daily | 1 to 200 daily | Constant with flare ups |
| Attack Duration | 15 mins to 3 hrs | 2 to 30 mins | Seconds to 10 mins | Months to years untreated |
| Autonomic Symptoms? | Yes | Yes | Yes | Yes |
| Agitation? | Yes | Yes | Sometimes | Yes |
| Migraine Features?*** | Yes | Yes | Rarely | Often |
| Triggers | Alcohol | Stress, exercise, alcohol | Touching face | Alcohol |
| Indomethacin Responsive? | No | Yes | No | Yes |
| Acute Treatment | Triptans, oxygen | None | Lidocaine IV for severe | None |
| Preventive Treatment | Verapamil, corticosteroids, galcanezumab, lithium | Indomethacin, verapamil, NSAIDs | Lamotigrine, oxcarbazepine, topiramate, gabapentin | Indomethacin |
SUNCT: Short-lasting unilateral neuralgiform headache attacks with conjunctival injection and tearing
SUNA: Short-lasting unilateral neuralgiform headache attacks with cranial autonomic symptoms (Autonomic symptoms: conjunctival injection, tearing, nasal congestion/runny nose, facial sweating, small pupil and/or droopy eyelid, eyelid swelling on affected side).
NSAIDs: nonsteroidal anti-inflammatory drugs.
*Conjuctival injection AND lacrimation (tearing) are present.
**Either conjuctival injection OR lacrimation is present, not both.
***Migraine features may include nausea, vomiting, light/noise sensitivity.
Mon, Jul 20, 26
Migraine Treatment in Pregnancy and Breastfeeding
Migraine hits hardest during the reproductive years. Here is what the latest evidence says about which migraine medications are safe during pregnancy and breastfeeding, from triptans and NSAIDs to topiramate,...
Read MoreMon, Jul 13, 26
Rimegepant for Migraine Prevention: Real-World Evidence
New real-world data on rimegepant for migraine prevention: a 75 mg every-other-day gepant that also treats attacks. What the GEMA study found on response rates, dosing, and why earlier use...
Read MoreMon, Jul 13, 26
Placebo Response in Migraine Trials: What a 126-Study Analysis Found
A new Neurology meta-analysis of 126 acute migraine trials found that about 1 in 9 people reach 2-hour pain freedom on placebo alone, and that placebo response has been rising...
Read More




